279 related articles for article (PubMed ID: 10768924)
1. Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes.
Vesy CJ; Kitchens RL; Wolfbauer G; Albers JJ; Munford RS
Infect Immun; 2000 May; 68(5):2410-7. PubMed ID: 10768924
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
Yu B; Hailman E; Wright SD
J Clin Invest; 1997 Jan; 99(2):315-24. PubMed ID: 9006000
[TBL] [Abstract][Full Text] [Related]
3. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein.
Hailman E; Albers JJ; Wolfbauer G; Tu AY; Wright SD
J Biol Chem; 1996 May; 271(21):12172-8. PubMed ID: 8647810
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein.
Levels JH; Marquart JA; Abraham PR; van den Ende AE; Molhuizen HO; van Deventer SJ; Meijers JC
Infect Immun; 2005 Apr; 73(4):2321-6. PubMed ID: 15784577
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein.
Wurfel MM; Hailman E; Wright SD
J Exp Med; 1995 May; 181(5):1743-54. PubMed ID: 7536794
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide (LPS) binding protein catalyzes binding of LPS to lipoproteins.
Wurfel MM; Wright SD
Prog Clin Biol Res; 1995; 392():287-95. PubMed ID: 8524933
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS.
Wurfel MM; Kunitake ST; Lichenstein H; Kane JP; Wright SD
J Exp Med; 1994 Sep; 180(3):1025-35. PubMed ID: 8064223
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid.
Wurfel MM; Wright SD
J Immunol; 1997 Apr; 158(8):3925-34. PubMed ID: 9103463
[TBL] [Abstract][Full Text] [Related]
9. Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms.
Hamann L; Alexander C; Stamme C; Zähringer U; Schumann RR
Infect Immun; 2005 Jan; 73(1):193-200. PubMed ID: 15618154
[TBL] [Abstract][Full Text] [Related]
10. Effect of plasma phospholipid transfer protein deficiency on lethal endotoxemia in mice.
Gautier T; Klein A; Deckert V; Desrumaux C; Ogier N; Sberna AL; Paul C; Le Guern N; Athias A; Montange T; Monier S; Piard F; Jiang XC; Masson D; Lagrost L
J Biol Chem; 2008 Jul; 283(27):18702-10. PubMed ID: 18458077
[TBL] [Abstract][Full Text] [Related]
11. Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides.
Munford RS; Hall CL; Lipton JM; Dietschy JM
J Clin Invest; 1982 Oct; 70(4):877-88. PubMed ID: 6749904
[TBL] [Abstract][Full Text] [Related]
12. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14.
Yu B; Wright SD
J Biol Chem; 1996 Feb; 271(8):4100-5. PubMed ID: 8626747
[TBL] [Abstract][Full Text] [Related]
13. Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface.
Kitchens RL; Wolfbauer G; Albers JJ; Munford RS
J Biol Chem; 1999 Nov; 274(48):34116-22. PubMed ID: 10567381
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14.
Tobias PS; Soldau K; Gegner JA; Mintz D; Ulevitch RJ
J Biol Chem; 1995 May; 270(18):10482-8. PubMed ID: 7537731
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide (LPS) binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14.
Han J; Mathison JC; Ulevitch RJ; Tobias PS
J Biol Chem; 1994 Mar; 269(11):8172-5. PubMed ID: 7510680
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection.
Jack RS; Fan X; Bernheiden M; Rune G; Ehlers M; Weber A; Kirsch G; Mentel R; Fürll B; Freudenberg M; Schmitz G; Stelter F; Schütt C
Nature; 1997 Oct; 389(6652):742-5. PubMed ID: 9338787
[TBL] [Abstract][Full Text] [Related]
17. Interactions of bacterial lipopolysaccharide and peptidoglycan with a 70 kDa and an 80 kDa protein on the cell surface of CD14+ and CD14- cells.
Triantafilou K; Triantafilou M; Dedrick RL
Hum Immunol; 2001 Jan; 62(1):50-63. PubMed ID: 11165715
[TBL] [Abstract][Full Text] [Related]
18. Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation.
Lamping N; Hoess A; Yu B; Park TC; Kirschning CJ; Pfeil D; Reuter D; Wright SD; Herrmann F; Schumann RR
J Immunol; 1996 Nov; 157(10):4648-56. PubMed ID: 8906845
[TBL] [Abstract][Full Text] [Related]
19. A hydrophobic cluster at the surface of the human plasma phospholipid transfer protein is critical for activity on high density lipoproteins.
Desrumaux C; Labeur C; Verhee A; Tavernier J; Vandekerckhove J; Rosseneu M; Peelman F
J Biol Chem; 2001 Feb; 276(8):5908-15. PubMed ID: 11083872
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKKϵ-IRF3 axis activation.
Tsukamoto H; Takeuchi S; Kubota K; Kobayashi Y; Kozakai S; Ukai I; Shichiku A; Okubo M; Numasaki M; Kanemitsu Y; Matsumoto Y; Nochi T; Watanabe K; Aso H; Tomioka Y
J Biol Chem; 2018 Jun; 293(26):10186-10201. PubMed ID: 29760187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
